(R)-MLN-4760 is primarily utilized in biochemical research as a selective inhibitor of angiotensin-converting enzyme 2 (ACE2). It plays a significant role in studying the physiological and pathological functions of ACE2, particularly in the context of cardiovascular and renal systems. Researchers employ (R)-MLN-4760 to investigate its potential therapeutic applications in conditions such as hypertension, heart failure, and diabetic nephropathy. Additionally, it is used to explore the role of ACE2 in viral infections, including its interaction with the SARS-CoV-2 virus, providing insights into viral entry mechanisms and potential antiviral strategies. The compound is also valuable in understanding the renin-angiotensin system (RAS) and its implications in various diseases.